» Articles » PMID: 20335292

Influence of Anxiety on Health Outcomes in COPD

Overview
Journal Thorax
Date 2010 Mar 26
PMID 20335292
Citations 102
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Psychological functioning is an important determinant of health outcomes in chronic lung disease. To better define the role of anxiety in chronic obstructive pulmonary disease (COPD), a study was conducted of the inter-relations between anxiety and COPD in a large cohort of subjects with COPD and a matched control group.

Methods: Data were used from the FLOW (Function, Living, Outcomes, and Work) cohort of patients with COPD (n=1202) and matched controls without COPD (n=302). Anxiety was measured using the Anxiety subscale of the Hospital Anxiety and Depression Scale.

Results: COPD was associated with a greater risk of anxiety in multivariable analysis (OR 1.85; 95% CI 1.072 to 3.18). Among patients with COPD, anxiety was related to poorer health outcomes including worse submaximal exercise performance (less distance walked during the 6-min walk test: -66.3 feet for anxious vs non-anxious groups; 95% CI -127.3 to -5.36) and a greater risk of self-reported functional limitations (OR 2.41; 95% CI 1.71 to 3.41). Subjects with COPD with anxiety had a higher longitudinal risk of COPD exacerbation in Cox proportional hazards analysis after controlling for covariates (HR 1.39; 95% CI 1.007 to 1.90).

Conclusion: COPD is associated with a higher risk of anxiety. Once anxiety develops among patients with COPD, it is related to poorer health outcomes. Further research is needed to determine whether systematic screening and treatment of anxiety in COPD will improve health outcomes and prevent functional decline and disability.

Citing Articles

Early, integrated palliative care for people with chronic respiratory disease: lessons learnt from lung cancer.

Walker A, Sullivan D, Nguyen P, Holland A, Smallwood N Ther Adv Respir Dis. 2025; 19:17534666241305497.

PMID: 39921545 PMC: 11807281. DOI: 10.1177/17534666241305497.


Association between impairment of lung function and risk of anxiety and depression in patients with chronic obstructive pulmonary disease-a systematic review.

Karlsen J, Jorgensen K, Weinreich U Syst Rev. 2024; 13(1):300.

PMID: 39633466 PMC: 11616382. DOI: 10.1186/s13643-024-02720-z.


Development and Validation of a Screening Tool for Generalized Anxiety and Major Depressive Disorder in Patients with Chronic Obstructive Pulmonary Disease.

Liu M, Yang X, Wang D, Fang J, Li B, An L Lung. 2024; 203(1):6.

PMID: 39612056 DOI: 10.1007/s00408-024-00767-2.


Symptoms of Anxiety and Depression Among Adults: United States, 2019 and 2022.

Terlizzi E, Zablotsky B Natl Health Stat Report. 2024; (213).

PMID: 39591466 PMC: 11616099. DOI: CS353885.


The Effect of Patient Sex on Treatment Outcomes in COPD: A Post Hoc Analysis of the IMPACT Trial.

Alberola A, Nogal N, Miranda A, Lipson D, Tombs L, Han M Chronic Obstr Pulm Dis. 2024; 11(6):591-603.

PMID: 39531369 PMC: 11703016. DOI: 10.15326/jcopdf.2024.0541.


References
1.
Tashkin D, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S . A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008; 359(15):1543-54. DOI: 10.1056/NEJMoa0805800. View

2.
. Cigarette smoking among adults--United States, 1997. MMWR Morb Mortal Wkly Rep. 1999; 48(43):993-6. View

3.
Goodwin R, Zvolensky M, Keyes K . Nicotine dependence and mental disorders among adults in the USA: evaluating the role of the mode of administration. Psychol Med. 2008; 38(9):1277-86. PMC: 7872214. DOI: 10.1017/S0033291708003012. View

4.
Sternfeld B, Ngo L, Satariano W, Tager I . Associations of body composition with physical performance and self-reported functional limitation in elderly men and women. Am J Epidemiol. 2002; 156(2):110-21. DOI: 10.1093/aje/kwf023. View

5.
Walters J, Wood-Baker R, Walls J, Johns D . Stability of the EasyOne ultrasonic spirometer for use in general practice. Respirology. 2006; 11(3):306-10. DOI: 10.1111/j.1440-1843.2006.00842.x. View